A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive

See also
Status	Clinical Trial	Phase
Completed	`NCT02283671` - Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B	Phase 1
Recruiting	`NCT01024985` - Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct	N/A
Recruiting	`NCT04601142` - Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism
Completed	`NCT03942952` - PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
Recruiting	`NCT05573711` - Restless Legs Syndrome in People With Neuromyelitis Optica Spectrum Disorder
Not yet recruiting	`NCT06118398` - Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
Recruiting	`NCT05566769` - Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD	N/A
Withdrawn	`NCT03829566` - Autologous Transplant To End NMO Spectrum Disorder	Phase 2/Phase 3
Recruiting	`NCT05403138` - Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders	Phase 2/Phase 3
Completed	`NCT03350633` - Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders	Phase 2/Phase 3
Recruiting	`NCT05356858` - An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients	Phase 2
Recruiting	`NCT05982925` - Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Active, not recruiting	`NCT00445367` - Biobank For MS And Other Demyelinating Diseases
Terminated	`NCT02398994` - A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis	Phase 3
Withdrawn	`NCT02087813` - Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses	Phase 1
Terminated	`NCT01339455` - Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica	Phase 1/Phase 2
Recruiting	`NCT02021825` - Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders	Phase 4
Active, not recruiting	`NCT04614454` - High Frequency Impulse Therapy for Neuropathic Pain in NMOSD	Phase 2
Recruiting	`NCT03370965` - Optic Neuritis Differential Diagnosis Study	N/A
Completed	`NCT01777412` - Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations	Phase 1

NCT number	NCT01892345
Study type	Interventional
Source	Alexion Pharmaceuticals
Contact
Status	Terminated
Phase	Phase 3
Start date	April 11, 2014
Completion date	July 17, 2018

A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms